Skip to main content
ACS Omega logoLink to ACS Omega
. 2022 Feb 15;7(8):7430. doi: 10.1021/acsomega.2c00749

Correction to “Feprazone Mitigates IL-1β-Induced Cellular Senescence in Chondrocytes”

Zhusong Huang, Jinfu Lan, Xi Gao
PMCID: PMC8892662  PMID: 35252733

The following minor errors need to be corrected:

On Page 9444, the Figure 4 legend should read: “Feprazone reduced the expressions of PAI-1 and p21 in IL-1β-challenged C-28/I2 chondrocytes. Cells were stimulated with IL-1β (10 ng/mL) in the presence or absence of Feprazone (20 μM). (A) mRNAs of PAI-1 and p21 and (B) proteins of PAI-1 and p21 (n = 5; ###, P < 0.001 vs the vehicle group; &, P < 0.05 vs the IL-1β group; &&, P < 0.01 vs the IL-1β group)”.

On Page 9447, reference 17 should be: “Fletcher, M. R.; Loebl, W.; Scott, J. T. Feprazone, a new anti-inflammatory agent. Studies of potency and gastrointestinal tolerance. Ann. Rheum. Dis.1975, 34, 190–194”.


Articles from ACS Omega are provided here courtesy of American Chemical Society

RESOURCES